NVWM LLC’s Dare Bioscience DARE Stock Holding History

NVWM LLC’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-43	Closed	-$1K	–	544
2021 Q4	$1K	Hold	43	–	–	﹤0.01%	485
2021 Q3	$1K	Buy	+43	New	+$848	﹤0.01%	482

Other funds holding DARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SAM

Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

NVWM LLC's DARE Position: Q1 2022 in Review

NVWM LLC sold out of Dare Bioscience (DARE) in Q1 2022, closing a stake of 43 shares — an estimated $1K sold.

NVWM LLC first reported a position in DARE in Q3 2021 and held it in 2 quarters. The position peaked at $1K in Q4 2021. 40 funds tracked by Wall St. Rank hold DARE as of Q1 2022.

NVWM LLC reported no remaining Dare Bioscience position as of Q1 2022 after selling out during the quarter.
NVWM LLC sold 43 Dare Bioscience shares in Q1 2022, an estimated $1K.
NVWM LLC first reported a position in Dare Bioscience in Q3 2021 and held it in 2 quarters.
NVWM LLC's Dare Bioscience position peaked at $1K in Q4 2021.
40 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2022.

Based on NVWM LLC's 13F filing for Q1 2022, filed 11 May 2022.